ESG

Mabpharm Limited (stock code: 2181.HK), as one of the leading biomedical enterprises in China, not only focuses on the development and production of innovative drugs but also demonstrates excellence in environment, society and governance (ESG) practices. Mabpharm Limited's sound organizational structure, clearly defined goals and vision, and unwavering commitment, and concrete actions demonstrates a strong sense of responsibility and mission, promoting sustainable development .


Organizational Structure

Mabpharm Limited's ESG management system is centered around the board of directors, with an ESG Management Committee overseeing all planning and implementation. The committee comprises senior executives and department heads to ensure that ESG principles are integrated into every aspect of the company's operations. Additionally, a dedicated ESG working group has been established to manage day-to-day activities and drive project initiatives, creating a top-down ESG management network.

Environmental

Mabpharm Limited recognizes the strong connection between the pharmaceutical industry and environmental protection. Throughout the R&D and production process, we are committed to minimizing waste and chemical emissions. To reduce its environmental impact, Mabpharm Limited has implemented a series of environmental management measures. We also actively promote the adoption of green pharmaceutical technologies, optimize drug R&D and production processes, and reduce resource consumption and carbon emissions. Additionally, Mabpharm Limited prioritizes the recovery and disposal of chemicals, ensuring that all operations comply with environmental standards and contribute to building a sustainable, green ecosystem.

Social

Mabpharm Limited has always placed patients at the heart of our mission. We are committed to ensuring medical fairness and accessibility, striving to guarantee patient safety and improve quality of life. In addition, Mabpharm Limited prioritizes the physical and mental health and career development of its employees, providing diverse training and development opportunities to help them realize their full potential. We also actively participate in community public welfare initiatives, giving back to the society and demonstrating its corporate social responsibility . These efforts have not only strengthened employee engagement and cohesion but also earned Mabpharm widespread recognition.

Governance

Mabpharm Limited has established a fair and effective corporate governance mechanism to ensure transparency, fairness, and efficient decision-making. The company has formulated and strictly implemented a series of business ethics and compliance policies, respecting patients' informed consent rights, protecting data and personal privacy, and ensuring the compliance of the drug development and commercialization process. Mabpharm Limited prioritizes the establishment of a robust risk management system to effectively mitigate risks at every stage, enhancing our ability to prevent risks and ensuring stable operations. The board of directors and management play a key role in ESG governance. Through strategic planning and division of responsibilities, they effectively drive the management actions and foster creativity across all levels of the organization.